Latest Announcements

Gallops Enterprise Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 to consider and approve the unaudited Financial Results of the Company for the quarter ended on June 30, 2026.

Sundaram Brake Linings Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, and the board of directors has approved the results along with an unmodified opinion from the statutory auditors.

Eveready Industries India Ltd's board meeting on August 8, 2026, considered and approved the unaudited financial results for the quarter ended June 30, 2026. The results, along with a limited review report, are available on the company's website.

Captain Pipes Ltd has announced its financial results for the quarter ended on 30.06.2026, with the Board of Directors approving standalone and consolidated unaudited financial results, and a limited review report by the statutory auditor.

Eveready Industries India Limited has submitted its financial results for the quarter ended June 30, 2026, to the National Stock Exchange of India Ltd. The Board of Directors has considered and approved the unaudited financial results (standalone and consolidated) for the quarter.

Advanced Enzyme Technologies Limited has informed the Exchange regarding Outcome of Board Meeting held on August 08, 2026. The Board has approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026. Additionally, the Board has approved the Buyback of fully paid-up equity shares having a face value of ? 2/- (Rupees Two only) each of the Company at a price not exceeding ? 500/- (Rupees Five Hundred only) per equity share. The Board has also approved the acquisition of the remaining stake of 4.28% Equity Shares from the other existing Shareholders of JC Biotech Private Limited and the infusion of additional funds not exceeding ? 20 million in Advanced Nutrazyme Private Limited.

Shrydus Industries Ltd has scheduled a board meeting on August 14, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Prithvi Exchange (India) Ltd has announced the outcome of its Board meeting held on August 08, 2026, where it considered and approved the unaudited financial results for the 1st quarter ended June 30, 2026. The results will be available on the company's website and published in newspapers as per the SEBI Listing Regulations.

Advanced Enzyme Technologies Limited has submitted its financial results for the quarter ended June 30, 2026, and approved a buyback of equity shares, acquisition of a remaining stake in JC Biotech Private Limited, and infusion of additional funds in Advanced Nutrazyme Private Limited.

James Warren Tea Ltd has announced the outcome of its Board meeting held on August 8, 2026. The Board reviewed and approved the unaudited financial results for the quarter ended June 30, 2026, and noted the limited review report issued by the statutory auditors. The company has also scheduled its 17th Annual General Meeting (AGM) to be held on September 21, 2026, and fixed September 20, 2026, as the cut-off date for e-voting and AGM.

Algoquant Fintech Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30.06.2026.

Pritika Auto Industries Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, along with the Limited Review Report of the Auditors. The Board of Directors has approved the reappointment of Mr. Aman Tandon and Mrs. Kritika Goyal as Independent Directors, and Mr. Ajay Kumar as Joint Managing Director. The company has also approved the reappointment of M/s. A.K Sood & Associates as Internal Auditor and M/s Verma Khushwinder & Co. as Cost Auditor. The financial results and related party transactions will be presented at the forthcoming Annual General Meeting.

Pritika Auto Industries Ltd has announced the outcome of its Board Meeting held on 8th August, 2026, where the Board approved the unaudited financial results for the quarter ended 30th June, 2026, and reappointed certain directors and auditors.

Advanced Enzyme Technologies Ltd approved un-audited financial results for Q2 2026, buyback of equity shares, and acquisition of remaining stake in JC Biotech Private Limited.

NMDC Steel Ltd has scheduled a board meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

The Andhra Sugars Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 4,537.92 lakhs and a basic and diluted EPS of Rs. 3.35. The company's revenue from operations was Rs. 37,756.78 lakhs, with an increase in profit mainly due to higher selling prices of chemical products.

Ambika Cotton Mills Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, which were reviewed by the Audit Committee and approved by the Board of Directors. The company reported a revenue from operations of ₹25,792, a profit/loss before exceptional items and tax of ₹3,454, and a basic earnings per share of ₹44.89.

Rushil Decor Limited has announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, along with the re-appointment of Mr. Rushil K. Thakkar as Managing Director for a further term of three years, and the appointment of M/s. Parikh & Majmudar as statutory auditors for five years.

Darshan Orna Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026, with a profit before tax of ₹5.99 lakhs and a net profit of ₹5.09 lakhs. The company's revenue from operations was ₹1,246.69 lakhs, and its expenses were ₹1,240.70 lakhs. The company's earnings per share for continuing operations was ₹0.01.

Purity Flexpack Ltd's board meeting outcome for approval of unaudited financial results for the quarter ended 30.06.2026, along with re-appointment of MD, revision in payment of remuneration to EDs, and re-appointment of independent directors.